121 related articles for article (PubMed ID: 33011551)
1. Alcohol consumption patterns across Europe and adherence to the European guidelines in coronary patients: Findings from the ESC-EORP EUROASPIRE V survey.
van de Luitgaarden IAT; Schrieks IC; De Bacquer D; van Oort S; Mirrakhimov EM; Pogosova N; Davletov K; Dolzhenko M; van Ballegooijen AJ; Kotseva K; Grobbee DE; Beulens JWJ;
Atherosclerosis; 2020 Nov; 313():35-42. PubMed ID: 33011551
[TBL] [Abstract][Full Text] [Related]
2. Chronic medication intake in patients with stable coronary heart disease across Europe: Evidence from the daily clinical practice. Results from the ESC EORP European Survey of Cardiovascular Disease Prevention and Diabetes (EUROASPIRE IV) Registry.
De Smedt D; De Backer T; Petrovic M; De Backer G; Wood D; Kotseva K; De Bacquer D
Int J Cardiol; 2020 Feb; 300():7-13. PubMed ID: 31744720
[TBL] [Abstract][Full Text] [Related]
3. Dietary measures among patients with coronary heart disease in Europe. ESC EORP Euroaspire V.
Marques-Vidal P; Jankowski P; De Bacquer D; Kotseva K;
Int J Cardiol; 2020 Mar; 302():5-14. PubMed ID: 31937454
[TBL] [Abstract][Full Text] [Related]
4. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
[TBL] [Abstract][Full Text] [Related]
5. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
[TBL] [Abstract][Full Text] [Related]
6. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in risk factor management and pharmacological treatment among CHD patients: Belgian results of the EUROASPIRE IV and EUROASPIRE V surveys.
Vynckier P; De Sutter J; De Pauw M; Vandekerckhove H; De Backer G; Vervaet P; Deweerdt N; Dendale P; Persu A; Janssen A; Chenu P; Kotseva K; Gevaert S; De Bacquer D; De Smedt D; ;
Acta Cardiol; 2023 Jul; 78(5):607-613. PubMed ID: 36779380
[TBL] [Abstract][Full Text] [Related]
8. Gender gap in risk factor control of coronary patients far from closing: results from the European Society of Cardiology EUROASPIRE V registry.
Vynckier P; Ferrannini G; Rydén L; Jankowski P; De Backer T; Gevaert S; De Bacquer D; De Smedt D;
Eur J Prev Cardiol; 2022 Mar; 29(2):344-351. PubMed ID: 33624111
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in cardiovascular risk factor awareness: Results from the ESC EORP EUROASPIRE V Registry.
Vynckier P; Kotseva K; Gevaert S; De Bacquer D; De Smedt D;
Int J Cardiol; 2022 Apr; 352():152-157. PubMed ID: 35122913
[TBL] [Abstract][Full Text] [Related]
10. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.
Kotseva K; De Backer G; De Bacquer D; Rydén L; Hoes A; Grobbee D; Maggioni A; Marques-Vidal P; Jennings C; Abreu A; Aguiar C; Badariene J; Bruthans J; Castro Conde A; Cifkova R; Crowley J; Davletov K; Deckers J; De Smedt D; De Sutter J; Dilic M; Dolzhenko M; Dzerve V; Erglis A; Fras Z; Gaita D; Gotcheva N; Heuschmann P; Hasan-Ali H; Jankowski P; Lalic N; Lehto S; Lovic D; Mancas S; Mellbin L; Milicic D; Mirrakhimov E; Oganov R; Pogosova N; Reiner Z; Stöerk S; Tokgözoğlu L; Tsioufis C; Vulic D; Wood D;
Eur J Prev Cardiol; 2019 May; 26(8):824-835. PubMed ID: 30739508
[TBL] [Abstract][Full Text] [Related]
11. Medical Treatment in Coronary Patients: Is there Still a Gender Gap? Results from European Society of Cardiology EUROASPIRE V Registry.
Vynckier P; Ferrannini G; Rydén L; Tokgözoğlu L; Bruthans J; Kotseva K; Wood D; De Backer T; Gevaert S; De Bacquer D; De Smedt D;
Cardiovasc Drugs Ther; 2021 Aug; 35(4):801-808. PubMed ID: 33068226
[TBL] [Abstract][Full Text] [Related]
12. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
[TBL] [Abstract][Full Text] [Related]
13. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
[TBL] [Abstract][Full Text] [Related]
14. Assessing the probability of risk factor control in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey.
Moerschel KS; De Bacquer D; De Backer G; Wood D; Kotseva K; Wellmann J; Prugger C
Eur J Prev Cardiol; 2022 Aug; 29(10):1465-1475. PubMed ID: 35709302
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of chronic kidney disease and its determinants in coronary heart disease patients in 24 European countries: Insights from the EUROASPIRE IV survey of the European Society of Cardiology.
Wagner M; Wanner C; Kotseva K; Wood D; De Bacquer D; Rydén L; Störk S; Heuschmann PU;
Eur J Prev Cardiol; 2017 Jul; 24(11):1168-1180. PubMed ID: 28503987
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry.
Cífková R; Lánská V; Bruthans J; Mayer O; Kotseva K; Wood D; Lovic D; De Sutter J; Reiner Z; Fras Z; Deckers J; Gotcheva N; Georgiev B; De Bacquer D;
J Hypertens; 2019 Oct; 37(10):2015-2023. PubMed ID: 31246889
[TBL] [Abstract][Full Text] [Related]
17. Association of longitudinal alcohol consumption trajectories with coronary heart disease: a meta-analysis of six cohort studies using individual participant data.
O'Neill D; Britton A; Hannah MK; Goldberg M; Kuh D; Khaw KT; Bell S
BMC Med; 2018 Aug; 16(1):124. PubMed ID: 30131059
[TBL] [Abstract][Full Text] [Related]
18. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.
De Backer G; Jankowski P; Kotseva K; Mirrakhimov E; Reiner Ž; Rydén L; Tokgözoğlu L; Wood D; De Bacquer D; ; ; ; ; ; ; ; ;
Atherosclerosis; 2019 Jun; 285():135-146. PubMed ID: 31054483
[TBL] [Abstract][Full Text] [Related]
19. 'From Kava to Lager'--alcohol consumption and drinking patterns for older adults of Pacific ethnic groups, and Europeans in the Diabetes Heart and Health Study (DHAHS) 2002-2003, Auckland New Zealand.
Sundborn G; Metcalf PA; Gentles D; Scragg R; Schaaf D; Dyall L; Black P; Jackson R
Pac Health Dialog; 2009 Feb; 15(1):47-54. PubMed ID: 19585734
[TBL] [Abstract][Full Text] [Related]
20. Adherence to Drinking Guidelines and Reasons for Alcohol Consumption Cessation in the Southern Cone of Latin America - Findings from the CESCAS Study.
van de Luitgaarden IAT; Gulayin PE; Gutierrez L; Calandrelli M; Mores N; Ponzo J; Lanas F; Schrieks IC; Grobbee DE; Beulens JWJ; Irazola V
Glob Heart; 2021 Jan; 16(1):2. PubMed ID: 33598382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
